The Cannabis Bankruptcy Wave: Why 2026 Is Different From Prior Cycles
By Sheeba M. | April 02, 2026 The Cannabis Bankruptcy Wave: Why 2026 Is Different From Prior Cycles TL;DR: A new wave of cannabis company bankruptcies and receiverships is reshaping the MSO landscape in 2026. Unlike earlier cycles driven by over-expansion, this round reflects structural balance sheet failures from sustained 280E tax burdens, high debt […]
CMS Medicare CBD Coverage April 2026: What It Means for Cannabis Investors
By Sheeba M. | April 02, 2026 CMS Medicare CBD Coverage April 2026: What It Means for Cannabis Investors TL;DR: A CMS Innovation Center pilot launching in April 2026 will allow Medicare to cover up to $500 annually for hemp-derived CBD products for qualifying beneficiaries — potentially unlocking a new revenue channel for CBD brands […]
Cannabis European Market Expansion: Canadian LPs vs. Domestic Operators in 2026
By Sheeba M. | April 02, 2026 Cannabis European Market Expansion: Canadian LPs vs. Domestic Operators in 2026 TL;DR: German cannabis reform unlocks €15B market opportunity as Canadian LPs face intensifying local competition. Cannabis European Market Expansion: Canadian LPs vs. Domestic Operators in 2026 TL;DR: Canada’s largest cannabis companies dominated European market entry, but shifting […]